Article
KRAS Mutation-Responsive miR-139-5p inhibits Colorectal Cancer Progression and is repressed by Wnt Signaling.
Theranostics - 1 Jan 2020
Du Feng, Cao Tianyu, Xie Huahong, Li Ting, Sun Lina, Liu Hao, Guo Hao, Wang Xin, Liu Qi, Kim Taewan, Franklin Jeffrey L, Graves-Deal Ramona, Han Weili, Tian Zuhong, Ge Minghui, Nie Yongzhan, Fan Daiming, Coffey Robert J, Lu Yuanyuan, Zhao Xiaodi
Abstract excerpt
Introduction: Colorectal cancer (CRC) frequently harbors KRAS mutations that result in chemoresistance and metastasis. MicroRNAs (miRNAs) are usually dysregulated and play important regulatory roles in tumor progression. However, the KRAS mutation-responsive miRNA profile in CRC remains uninvestigated. Methods: miR-139-5p was identified and evaluated by small RNA sequencing, qRT-PCR and in situ hybridization. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
